1.0Myanmar News Gazettehttps://myanmarnewsgazette.comadminhttps://myanmarnewsgazette.com/author/admin/rich600338<blockquote class="wp-embedded-content" data-secret="dPztWyoxWS"><a href="https://myanmarnewsgazette.com/junshi-biosciences-announces-acceptance-of-nda-for-vv116-in-china/">Junshi Biosciences Announces Acceptance of NDA for VV116 in China</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://myanmarnewsgazette.com/junshi-biosciences-announces-acceptance-of-nda-for-vv116-in-china/embed/#?secret=dPztWyoxWS" width="600" height="338" title="“Junshi Biosciences Announces Acceptance of NDA for VV116 in China” — Myanmar News Gazette" data-secret="dPztWyoxWS" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script> /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); </script> SHANGHAI, China, Jan. 17, 2023 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced today that the new drug application (“NDA”) for Deuremidevir Hydrobromide Tablets (project code: JT001/VV116, “VV116”), an oral nucleoside analog anti-SARS-CoV-2 […]https://ci3.googleusercontent.com/proxy/dRxM2C5PGh-5vd5-nvXgweZBNXH2HbNVDAMQJelxTV59H2U0aXsY962k81W18tqy_ICKYK9Gp9cfNvLnBT65bKZeCP5gRcGEPiuPxI2TM4CtRYFkggnP7anpEsfTRDo3qXCXfwdniFm74MSa-O78gnsJA8kyXUBlPzOFUFyUMi2SppxhR9J9Rp9YY_C7tA=s0-d-e1-ft#https://ml.globenewswire.com/media/ZWMyYTc2ZWQtMzg4Mi00ODIxLTkxMzQtMWI3NjlhMjdhOWFhLTEyMDY5Mjg=/tiny/Junshi-Biosciences.png